Your browser doesn't support javascript.
loading
Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR study.
Michael, Michael; Liauw, Winston; McLachlan, Sue-Anne; Link, Emma; Matera, Annetta; Thompson, Michael; Jefford, Michael; Hicks, Rod J; Cullinane, Carleen; Hatzimihalis, Athena; Campbell, Ian G; Rowley, Simone; Beale, Phillip J; Karapetis, Christos S; Price, Timothy; Burge, Mathew E.
Affiliation
  • Michael M; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia. Michael.Michael@petermac.org.
  • Liauw W; Department of Medical Oncology, St. George's Hospital, Sydney, Australia.
  • McLachlan SA; Department of Medical Oncology, St. Vincent's Hospital, Melbourne, Australia.
  • Link E; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Matera A; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Thompson M; Division of Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Jefford M; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.
  • Hicks RJ; Division of Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Cullinane C; Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Hatzimihalis A; Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Campbell IG; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Rowley S; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Beale PJ; Department of Medical Oncology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Karapetis CS; Department of Medical Oncology, Flinders Medical Centre, Flinders Centre for Innovation in Cancer, Adelaide, Australia.
  • Price T; Department of Medical Oncology, The Queen Elizabeth Hospital, Adelaide, Australia.
  • Burge ME; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Australia.
Cancer Chemother Pharmacol ; 88(1): 39-52, 2021 07.
Article in En | MEDLINE | ID: mdl-33755789
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Irinotecan Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Journal: Cancer Chemother Pharmacol Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Irinotecan Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Journal: Cancer Chemother Pharmacol Year: 2021 Document type: Article Affiliation country: